Evaluation of a novel high-capacity dry plasma biosampling-lateral flow device for the testing of traumatic brain injury protein biomarkers.
BACKGROUND AND PURPOSE Current blood-based diagnostic tests for traumatic brain injury (TBI), such as those measuring UCH-L1 and GFAP, require venous whole blood or plasma samples collection and cold-chain handling. No FDA-cleared TBI test currently supports capillary blood or dried sample formats. We propose incorpora...